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DOI: 10.1039/b822835cWe fabricated de novo biocompatible mineral plasmon resonants for
localized and systemic treatment of cancer. Biodegradable calcium-
phosphate gold nanocomposites were synthesized for inducing
a superior surface plasmon resonance effect. The combination of
therapeutic antibody, Erbitux and NIR laser with nanocomposites
demonstrated the potential for selective bimodal cancer treatment
by combination of EGFR-induced signaling inhibition as a systemic
treatment and localized photothermal effects caused by the NIR
laser.Surface plasmon resonance (SPR) effects from noble metal nano-
structures have emerged as a highly promising localized photo-
thermal cancer therapy.1–4 In particular, the plasmonic gold
nanostructures such as core-shell nanocomposites,5–8 nanorods9–11
and nanocages12–15 have recently been developed because they can
strongly absorb near infrared (NIR) light for localized heating to
ablate the cancer cells without damage to normal tissue or blood.16
For highly selective and efficient photothermal cancer therapy, thus,
the synthesis of well-tailored gold nanostructures is vital for: (i)
enhanced plasmon resonance effect by NIR light for sufficient pho-
tothermal effect with minimal dose amounts,17 (ii) biocompatibility
for a reduction in unwanted immune responses,18 (iii) targeted
delivery to the specific cancerous cells by bio-conjugation with a tar-
geting moiety to mitigate the damage to healthy tissue19 and (iv)
collapse of resonant structure after photothermal treatment to reduce
the side effects from unnecessary NIR light.20 Furthermore, the use of
a therapeutic antibody, which inhibits the metabolism of cancer cells
for growth and proliferation, may increase the systemic treatmentaDepartment of Chemical and Biomolecular Engineering, Yonsei
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nanostructures.21
Herein, we report a novel strategy for bimodal cancer treatment
using a biocompatible mineral plasmon resonant for a localized
photothermal treatment and a therapeutic antibody for a systemic
treatment (Fig. 1). To prepare calcium phosphate-gold nano-
composites (CPGNs) as photothermal agents, mineral calcium
phosphate nanoparticles (CPNs) were synthesized as dielectric cores
because CPNs are highly biocompatible and biodegradable in the
lysosomal site of a cell due to a low pH (<4) in comparison to
conventional silica nanoparticles.21–23 After all, conventional silica
nanoparticles are not degradable under a proton-rich intracellular
environment, while CPNs can be easily dissolved by protons with
calcium and phosphate ions. Besides, cancer cells provide more acidic
environments compared to normal cells. Subsequently, the surface of
CPNs is modified to provide amine groups for a generation of a gold
nano-layer by the seed-mediated growth method (Fig. 1a).24
Furthermore, CPGNs are linked with a chimeric humanized mono-
clonal antibody, Erbitux (ERB), for targeting toward the epidermal
growth factor receptor (EGFR) and an additional therapeutic effect
by inhibition of the EGFR signaling pathway, a key pathway for
a carcinogenesis (Fig. 1b).25,26
CPNs were synthesized by a chemical precipitation method27,28 and
their ellipsoidal morphology was confirmed by a transmission elec-
tron microscope (TEM) image (see ESI†). For generation of a gold
overlayer on the surface of the CPNs, we modified the hydroxylFig. 1 Conceptual illustration for localized and systemic cancer treat-
ment using intelligent mineral plasmon resonants; a) anti-EGFR anti-
body (Erbitux, ERB) conjugation onto calcium phosphate-gold
nanocomposites (CPGNs), b) bimodal cancer treatment using
ERB-CPGNs and NIR laser, and c) biodegradation of CPGNs after
treatments.
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Fig. 2 a) TEM image of CPGNs (scale bar means 100 nm). b) UV-Vis
absorbance spectra of CPNs, CPNs-GNPs and CPGNs. The character-
istic absorbance of CPGNs was shifted to the NIR region due to the
formation of the gold overlayer. c) Relative degradation ratio of CPGNs
at pH 4 and 5 compared to the concentration of calcium ion at pH 7.4.
Fig. 3 a) Relative fluorescence intensity (DFI/FInon-treatment, FI: fluo-
rescence intensity) by FACS analysis for A431 and MCF7 cells treated
with ERB-CPGNs and IRR-CPGNs, respectively (* and **: p < 0.01). b)
TEM image of A431 cells treated with ERB-CPGNs (scale bar means 5
mm). ERB-CPGNs were internalized by receptor-mediated endocytosis,
and appear as black dots. The inset is a high magnification image (scale
bar means 1 mm).groups on the surface of CPNs with amine groups using 3-amino-
propyl trimethoxysilane (APTMS) and the amine groups of aminated
CPNs were verified at 400.7 eV (N 1s) by X-ray photoelectron
spectroscopy (ESI†). To generate nucleation sites for the formation
of the gold overlayer, gold nanoparticles (GNPs, 2 nm) were
synthesized as seeds by the gold salt reduction method and were
attached on the surface of CPNs by electrostatic interaction between
the amine group and gold (CPNs-GNPs, ESI†). Then, ellipsoidal
CPGNs were successfully synthesized after the growth of the reticular
gold overlayer on the surface of CPNs by the gradual reduction of
gold salts. In Fig. 2a, the TEM image indicates the ellipsoidal
morphology with an aspect ratio of ca. 4.7, which was smaller than
that of naked CPNs (ca. 6.5) due to generation of the 10 nm thick
nanolayer on CPNs. We then performed an elemental analysis of
CPNs-GNPs and CPGNs for Ca, P and Au atoms by energy-
dispersive X-ray spectroscopy and found that Au components were
increased from 5.0% (CPNs-GNPs) to 37.2% (CPGNs) after the
complete formation of the gold nanolayer on the surface of
the CPNs-GNPs (ESI†). From the X-ray diffraction pattern of the
CPGNs, moreover, we observed that the characteristic features of
the CPNs had vanished after the CPNs were fully covered by the gold
nanolayer (ESI†). To further investigate the optical plasmon peak of
the CPGNs, we used a UV-Vis spectrometer to obtain the absorption
spectra. The maximum absorbance of CPNs-GNPs was observed at
530 nm and was red-shifted to 920 nm after the gold nanolayer
formation (CPGNs) due to the SPR effect (Fig. 2b). Since the
geometrical characteristics of the CPGNs included an ellipsoidal
shape and core/overlayer structure, we expected a higher SPR effect
through the combination of two plasmonic properties arising from i)
the oscillation of electrons along the longitudinal and transverse axes
of ellipsoidal CPGNs and ii) hybridized plasmons on the inner
surface of the layer and the outer layer surface (core/overlayer).29
From a comparative study of the calculated extinction spectra for
ellipsoidal and spherical CPGN, and spherical gold-silica core-layer
(ESI†), we observed the plasmon peak of the ellipsoidal CPGN in the
NIR region (700–1000 nm). Moreover, a simulation study demon-
strated that ellipsoidal CPGNs produce a sufficiently strong SPR
effect in the NIR region rather than spherical CPGNs and conven-
tional silica-gold nanoshell structures (ESI†).
To evaluate the biodegradability of CPGNs, UV-Vis absorption
spectra of CPGNs under various pH conditions were analyzed for 5
days (ESI†). During the fabrication of the gold overlayer, the
attached gold nanoparticles as seeds on the surface of CPNs were
grown by a reduction process using tetrachlorolaurate(III) trihydrate
and formaldehyde. This consequently led to the formation ofThis journal is ª The Royal Society of Chemistry 2009a continuous and reticular gold overlayer (ESI†).8 Thus, CPNs can be
degraded under an acidic environment like the intracellular lysosomal
site. After exposure to the excess protons, the main peak of CPGNs in
the NIR region was blue-shifted under the acidic environment and
the absorbance was also decreased due to degradation of CPNs
(Fig. 1c and ESI†). Moreover, the relative degradation ratio of
CPGNs at pH 4 compared to pH 7.4 was 77.3% calculated using the
relative concentration of released calcium ions, which is obtained by
inductively coupled plasma mass spectrometry (Fig. 2c). Therefore,
CPGNs internalized into cancer cells can be degraded in an acidic
biological environment and reduce possible side effects such as
unwanted immune responses and unnecessary photothermal effects.
For targeted delivery of CPGNs toward cancer cells, the anti-
EGFR antibody, ERB, was conjugated on to the surface of the
CPGNs by an electrostatic interaction between CPGNs and the N
terminus of the antibody.30 The colloidal stability of prepared ERB-
CPGNs was determined from their resistance to sodium chloride and
pH-induced aggregation using laser scattering (ESI†). ERB-CPGNs
continuously maintained stable conditions even after 2 weeks because
negatively charged ERB-CPGNs (around20 mV) were stabilized in
the aqueous phase by electrostatic repulsion. Twenty equivalent
ERBs were conjugated on the surface of CPGN as evaluated using
a bicinchoninic acid (BCA) protein assay kit (Pierce). Subsequently,
the targeting efficiencies of ERB-CPGNs for EGFR-abundant A431
cells and EGFR-deficient MCF7 cells were evaluated by fluorescence
activated cell sorting analysis. Herein, CPGNs were conjugated with
human IgG as an irrelevant antibody (IRR-CPGNs) for the control
experiment. In Fig. 3a, ERB-CPGNs for A431 cells exhibited 171
times higher targeting potential than IRR-CPGNs due to the binding
affinity of anti-EGFR antibody, ERB for EGFR (*p < 0.01) and
A431 cells treated with ERB-CPGNs demonstrated 216 times
stronger fluorescence intensity than MCF7 cells treated with ERB-
CPGNs due to the difference in EGFR expression level between
A431 and MCF7 cells (**p < 0.01). In addition, the confocal
microscopic image indicated a remarkable cellular affinity of ERB-
CPGNs and receptor-mediated endocytosis into A431 cells (ESI†).
The fluorescent green color from ERB-CPGNs was clearly observed
around nuclei stained with 40,6-diamidino-2-phenylindole. The
successful internalization of ERB-CPGNs into A431 cells could be
also observed by TEM imaging (Fig. 3b). Therefore, ERB-CPGNsJ. Mater. Chem., 2009, 19, 2902–2905 | 2903
provided abundant possibilities for effective localized photothermal
and systemic treatment of cancer.
In order to assess the therapeutic efficacies of ERB-CPGNs as
cancer cell ablation agents, A431 or MCF7 cells were incubated with
ERB-CPGNs and IRR-CPGNs (100 mg) for 4 hours in the well
plates (4  103 cells/well). Each incubated cell was then washed for
elimination of un-reacted CPGNs and further incubated for 72 hours.
After NIR laser exposure (820 nm and 25 W/cm2 for 5 minutes), the
cell viabilities were evaluated using the calcein AM (1 mM) staining
method.31 Calcein AM is a membrane-permeant green fluorescent cell
marker that is hydrolyzed by endogenous esterase, and consequently
emits fluorescence in the cytoplasm of live cells. In Fig. 4a, ERB-
CPGNs partially inhibited the EGFR signaling pathways for growth
and proliferation of A431 cells in comparison to only A431 cells
irradiated by a NIR laser. After irradiation using a NIR laser (820 nm
and 25 W/cm2 for 5 minutes) of A431 cells treated with ERB-CPGNs,
generated photothermal heat from CPGNs increased the temperature
up to 49.7 C within 5 minutes. This effective photothermal
phenomenon comes from the strong SPR effect of ellipsoidal CPGNs
that was sufficient to denature the intracellular proteins, thus con-
verting the exposure site to a dark color for A431 cells treated with
ERB-CPGNs. The results demonstrated that the photothermal
phenomena using CPGNs can be easily generated with a small dose
of CPGNs and low power source compared to silica based gold
nanoshells.21 For quantification of the therapeutic efficacies for the
combination of ERB-CPGNs and NIR laser, furthermore, cell
viabilities of A431 and MCF7 cells treated with ERB-CPGNs or
IRR-CPGNs under NIR laser irradiation or in the absence of NIR
laser exposure were further investigated by MTT assay (Fig. 4b). The
therapeutic efficacy of ERB-CPGNs without laser irradiation on
A431 cells was approximately 57.0  0.8%, 4.2 times higher
compared to the experiment of NIR laser irradiation only. Moreover,
the therapeutic efficacy by ERB-CPGNs under NIR laser irradiation
(820 nm and 25 W/cm2 for 5 minutes) for A431 cells was 77.0% (*p <
0.01). In contrast, EGFR-deficient MCF7 cell lines treated with
ERB-CPGNs or IRR-CPGNs exhibited insignificant therapeutic
efficacies, even after NIR laser exposure. These results demonstrateFig. 4 a) Fluorescence microscopic images of A431 cells stained with
calcein AM after treatment with laser only, ERB-CPGNs and ERB-
CPGNs + laser (scale bar means 1 mm) (first column). Infrared ther-
mographic images of A431 cells treated with laser only, ERB-CPGNs and
ERB-CPGNs + laser (scale bar means 500 mm) (second column). In the
last row, the dotted circle indicates the NIR laser exposure area. b)
Therapeutic efficacy assessed by MTT assay in A431 or MCF7 cells
incubated with ERB-CPGNs and IRR-CPGNs, with or without expo-
sure to the NIR laser (* and **: p < 0.01).
2904 | J. Mater. Chem., 2009, 19, 2902–2905that the combination of ERB-CPGNs and NIR laser can achieve the
bimodal treatment of cancer by localized photothermal therapy from
the SPR effect of CPGNs and systemic treatment from the inhibition
of cellular signaling transduction of cancer cells.Conclusions
In summary, we have successfully formulated ERB-CPGNs as
bimodal therapeutic agents for effective epithelial cancer therapy.
CPGNs have ellipsoidal CPNs as the dielectric core and an outer gold
nanolayer, which makes them high-efficient SPR-inducing plasmonic
materials for hyperthermia. The biodegradation capability of CPNs
is well suited for applications in the biomedical field. The anti-EGFR
antibody, ERB, when conjugated on the surface of ERB-CPGNs
efficiently inhibited the growth and proliferation of EGFR-abundant
cancer cells and displayed remarkable selectivity. In the future, in vivo
study will be essential to verify extra uncertain parameters such as
thermal ablation efficacy of solid tumors, NIR light penetration
depth, biodegradability and blood circulation as well as bio-distri-
bution. We envision that biocompatible plasmonic CPGNs could
improve nano-medicinal potential for better treatment of cancer
among possible photothermal therapeutic methodologies.Acknowledgements
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Gold-layered Calcium Phosphate Plasmonic Resonants for Localized 
Photothermal Treatment of Human Epithelial Cancer 
 
Jinyoung Kang, Jaemoon Yang, Jaewon Lee, Seung Jae Oh, Seyoung Moon, Hong Jae Lee, Sangcheon 
Lee, Joo-Hiuk Son, Donghyun Kim, Kwangyeol Lee, Jin-Suck Suh, Yong-Min Huh* and Seungjoo 
Haam* 
 
Materials: Calcium hydroxide, phosphoric acid, tetrachloroaurate (III) trihydrate, tetrakis 
(hydroxymethyl) phosphonium chloride solution, sodium hydroxide, 3-aminopropyltrimethoxysilane, 
potassium carbonate and formaldehyde were purchased from Sigma-Aldrich Chemicals and phosphate 
buffered saline (PBS, 10 mM, pH7.4) was purchased from Hyclone and used without further purification. 
Human immunoglobulin G (IgG) as an irrelevant antibody and FITC-labeled goat anti-human IgG were 
purchased from ZyMaxTM. Erbitux® was purchased from Roche Pharmacuetical Ltd. Sephacryl S-300 
and calcein AM were purchased from Amersham Biosciences and Molecular Probes, respectively. 
 
Synthesis of calcium phosphate nanoparticles (CPNs): Calcium phosphate nanoparticles 
(CPNs) were synthesized by a chemical precipitation and hydrothermal technique according to a 
previously published protocol with some modifications.1 An aqueous solution of phosphoric 
acid (0.3 M, 300 mL) was added to a vigorously stirred aqueous solution of calcium hydroxide 
(0.25 M, 625 mL) in a dropwise manner at a rate of 1 mL/min at 60°C. After completion of the 
phosphoric acid addition, the pH of the suspension was adjusted to pH 7.0. After aging, CPNs 
were purified and collected by repeated washing with distilled water and centrifugation at 2,500 
rpm for 20 minutes (repeated 5 times). The final product of CPNs was obtained by freeze-drying. 
 
Synthesis of calcium phosphate-gold nanocomposites: Gold nanoparticles (GNPs, ~2 nm) 
were prepared by the reduction of tetrachlorolaurate (III) trihydrate (2 mL of 1.0 wt%) in the 
presence of a tetrakis (hydroxymethyl) phosphonium chloride solution (12 µL) and sodium 
hydroxide (0.5 mL of 1 M) solution as a reducing agent for 7 minutes at room temperature. The 
surface of CPNs was modified by self-assembly of 3-aminopropyltrimethoxysilane (5 µL) and 
CPNs (40 mg) in 5 mL of distilled water at 70oC for 3 hours. The aminated CPNs were purified 
by centrifugation and re-dispersed in distilled water (0.5 mL). X-ray photoelectron spectroscopy 
(XPS) was used to confirm the synthesis of aminated CPNs. Aminated CPNs (40 mg) were 
stirred with an excess of GNPs (7 × 1014 particles/5 mL). The amine group at CPN surface was 
used as an attachment site for binding of colloidal GNPs, which then served as nucleation sites 
for further growth by reduction of gold salts using formaldehyde. This consequently led to the 
formation of a continuous and reticular gold layer. The gold salts solution was prepared by 
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adding potassium carbonate (25 mg) into tetrachlroloaurate (III) trihydrate (50 mL of 0.02 wt%). 
Two hundred µL of CPNs-GNPs solution was mixed with the gold salts solution (4 mL) and 
formaldehyde (80 µL) for 5 minutes. After a 2-fold reduction of gold on CPN-GNPs, CPGNs 
were formed and purified by repeated washing with distilled water and centrifugation at 15,000 
rpm for 20 minutes (repeated 5 times). 
 
Degradation test: The synthesized CPNs can be degraded in an acidic environment according 
to the following reaction (eq 1).[2] To evaluate the degradation ratio of CPNs, CPNs (4 mg) was 
immersed in various range of pH solution (5 mL; pH 3, 4, 5, 6 and 7) for 24 hours and 
transmittance was measured using UV-Vis spectroscopy at 240 nm (Figure S7). Furthermore, 
the amount of released calcium ions from CPGNs was investigated by inductively coupled 
plasma mass spectrometry (ICP-MS) at various pH conditions (pH 4, 5 and 7.4). CPGNs (5 
mg/mL, 5 mL) was immersed in at each solution for 24 hours and treated with aqua regia which 
is 3 : 1 mixture of HCl : HNO3, and evaporated overnight at 110°C and 4 mL of distiled water 
was added for measuring using ICP-MS. In Figure 1c, relative degradation ratios were 
calculated using the ratio of calcium ion at pH 4 or 5 to calcium ion at pH 7.4. To confirm 
change of plasmon peaks during CPGNs degradation, on the other hands, UV-Vis absorption 
spectra of CPGNs at various pH conditions (pH 3, 4, 5, 6 and 7.4) were analyzed after 120 
hours. 
Ca10(PO4)6(OH)2 + 2H+ ↔ 10Ca2+ + 6PO43- + 2H2O    (eq 1) 
 
Simulation of the extinction spectra of CPNGs: For theoretical analysis of the extinction 
spectra, a Mie calculation of inhomogeneous ellipsoids was conducted, assuming smooth 
particle geometry. The surface of the particle is described as: 
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where a, b and c with subscripts i and o correspond to the inner and outer radii of the x, y, and z 
axis, respectively, and ξ, η and ζ are derived from the ellipsoidal coordinates. Note in this case 
that b = c ≤ a, which corresponds to a prolate ellipsoid with a principle axis coinciding with the 
x axis. To obtain an extinction cross-section of the particles in response to the field in the x, y 
and z-axes, the polarizability, α(x, y, z) in each axis was first calculated as: 
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where the eccentricities of the inner (superscripted i) and outer (superscripted o) ellipsoids (Lx, 
Ly and Lz) are defined as: 
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In Eq. (3), υ = 4πaoboco is the volume of the particle, 
iii
ooo
cba
cbaf =  is the volume fraction of the 
inner ellipsoid, and ),2,1( mε  is complex dielectric constant of: 1; inner material, 2; outer 
material, and m; surrounding medium, respectively. From the description of the scattered 
electric fields, the extinction cross-section, Cext was obtained from the polarizability calculation 
with the following relationship: 
},Im{αkCext =                        (5) 
where the wave vector k is defined as k = 2π/λ. 
The extinction spectra of three different types of plasmonic core-shell nanoparticles (ellipsoidal 
CPGNs, spherical CPGNs and spherical silica-gold core-shell structures) were calculated for 
comparison. The dielectric constants of gold and water were obtained from the experimental 
measurements and were interpolated in the wavelengths of interest (400 ~ 1,200 nm).3 The 
refractive index of CPNs (1.651) and silica nanoparticles (1.460) were assumed to be constant 
over the range of wavelengths. The major axis (a) and minor axis (b = c) of the ellipsoidal CPNs 
was 60 nm and 10 nm, respectively. The thickness of gold shell for CPGNs was 10nm for 
consistence with the experimental data. The both extinction spectra of the spherical CPGNs and 
silica gold nanoshells (a = b = c = 18.2 nm) were calculated based on the same core volume and 
gold shell thickness with the ellipsoidal CPGNs. In Figure S6, the ellipsoidal CPGNs exhibited 
higher extinction spectra at NIR region rather than spherical CPGNs and silica gold nanoshells. 
 
Conjugation of ERB with CPGNs: In order to conjugate ERB (Erbitux®, anti-EGFR antibody) 
with CPGNs, 2 mg of ERB was mixed with 4 mg of CPGNs in the PBS (pH 7.4, 10 mM) at 4oC. 
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After 4 hours, ERB-CPGNs were purified with a Sephacryl S-300 column. The quantity of 
conjugated ERB onto the surface of CPGNs was evaluated by a BCA protein assay (Thermo 
Fisher Scientific Inc.) and 20 equivalent ERB was conjugated on to CPGNs. Similarly, for 
control experiments, the irrelevant (IRR) human immunoglobulin G (IgG) antibody was 
conjugated with CPGNS. The IRR-conjugated CPGNs was synthesized with the same manner 
as described for ERB-CPGNs. 
 
Cellular affinity test: The epidermoid carcinoma A431 and MCF7 cell lines were obtained 
from American Tissue Type Culture (ATCC, Rockville, MD) and cultured. Briefly, the cells 
(1×105 cells/mL) were seeded in 100 ф Corning culture dishes (10 mL/dish) with Dulbecco's 
Modified Eagle Medium supplemented with 10% fetal bovine serum (FBS) and 1% antibiotics 
and incubated at 37 oC in a humidified atmosphere composed of 5% CO2. Fluorescence-
activated cell sorting (FACS) analysis was performed to determine the affinity of ERB-CPGNs 
(1 mg/mL, 200 μL) for A431 and MCF7 cells, respectively. A431 and MCF7 cells were washed 
with buffer (2 % FBS and 0.02 % NaN3 in PBS) and then the cells were incubated with ERB-
CPGNs and IRR-CPGNs for 1 hour at 4 oC, respectively. The temperature was maintained at 
4oC in order to avoid non-specific binding through endocytosis without receptor-mediated 
uptake. The treated cells were washed three times with an FITC-labeled goat anti-human IgG 
for 45 minutes at 4oC in the dark room. Finally, the cells were suspended in 400 μL PBS and 
stored at 4oC prior to FACS analysis (Becton Dickinson, Mountain View, California, USA). 
 
Investigation of therapeutic efficacy: A431 and MCF7 cells (4×103 cells/well) were incubated 
in 96-well plates for 24 hours. Target cells were incubated with ERB-MGNCs or IRR-MGNCs 
(1 mg/mL, 100 μL) at 37oC. After 4 hours, an equal volume of 10% FBS was added to each of 
the wells, and the cells were incubated for an additional 72 hours. During exposure to an NIR 
laser, thermographic data were recorded with an infrared thermal camera (Thermographic 
System, AXT100) with time intervals of 1 second over a course of 5 minutes, and the 
temperature of the cells was then calculated from the images using Thermographic System 
software. After exposure to an NIR laser (820 nm and 25 W/cm2 for 5 minutes), the cells were 
incubated for 2 hours at 37oC. The distribution of live and dead cells after staining with a 
calcein AM (l μM) was observed using a fluorescence microscope. The therapeutic efficacies 
were determined by calculating the differences between cell viabilities under treated and non-
treated conditions (n=3). 
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Figure S1. TEM images of CPNs (scale bar means 100 nm). 
 
 
 
 
 
 
Figure S2. X-ray photoelectron spectroscopy for CPNs and aminated CPNs (CPNs-
NH2). 
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Figure S3. TEM images of CPNs-GNP (scale bar means 100 nm). 
 
 
 
 
Figure S4. Energy-dispersive X-ray spectroscopy spectra of a) CPNs-GNP and b) 
CPGNs, and c) Au compositions of CNPs-GNPs and CPGNs, repectively. 
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Figure S5. X-ray diffraction patterns of CPGNs and CPNs. 
 
 
 
 
Figure S6. Comparison of the calculated extinction spectra for ellipsoidal CPGN, 
spherical CPGN and spherical silica-gold core-shell (gold thickness = 10 nm). 
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Figure S7. a) Transmittance of CPNs at various pH conditions to examine the 
potential for biodegradability. b) The photograph show the turbidities of CPN solutions 
according to the degree of degradation (pH 3 ~ 7). 
 
 
 
 
Figure S8. UV-Vis absorbance spectra of CPGNs at pH 3, 4, 5, 6 and 7.4 after 120 
hours. 
Supplementary material (ESI) for Journal of Materials Chemistry 
This journal is © The Royal Society of Chemistry 2009 
 
Figure S9. Particle size and zeta potential of ERB-CPGNs plotted against various 
(a) pH conditions and (b) NaCl concentrations. 
 
 
 
 
Figure S10. FACS analysis of a) A431 and b) MCF7 cells incubated with ERB-
CPGNs and IRR-CPGNs, respectively. 
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Figure S11. Confocal microscope image of A431 cells treated with ERB-CPGNs 
(scale bar means 5 μm). 
 
 
 
 
Figure S12. Temperature variations for incubation wells of a) only CPGNs solution, 
b) A431 cells treated with ERB-CPGNs and c) non-treated A431 cells after NIR laser 
irradiation (820 nm and 25 W/cm2 for 5 minutes), respectively. 
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Figure S13. Fluorescence microscopic images of A431 or MCF7 cells stained with 
calcein AM for each after treatment; non-treatment, laser only, IRR-CPGNs, IRR-
CPGNs + laser, ERB-CPGNs and ERB-CPGNs + laser, respectively (scale bar means 1 
mm). 
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